Jump to main content
Jump to site search

Issue 1, 2017
Previous Article Next Article

Exploring inhibitor structural features required to engage the 216-loop of human parainfluenza virus type-3 hemagglutinin-neuraminidase

Author affiliations

Abstract

Human parainfluenza virus type-3 is a leading cause of acute respiratory infection in infants and children. There is currently neither vaccine nor clinically effective treatment for parainfluenza virus infection. Hemagglutinin-neuraminidase glycoprotein is a key protein in viral infection, and its inhibition has been a target for inhibitor development. In this study, we explore the structural features required for Neu2en derivatives to efficiently lock-open the 216-loop of the human parainfluenza virus type-3 hemagglutinin-neuraminidase protein.

Graphical abstract: Exploring inhibitor structural features required to engage the 216-loop of human parainfluenza virus type-3 hemagglutinin-neuraminidase

Back to tab navigation

Supplementary files

Publication details

The article was received on 12 Sep 2016, accepted on 04 Oct 2016 and first published on 05 Oct 2016


Article type: Research Article
DOI: 10.1039/C6MD00519E
Citation: Med. Chem. Commun., 2017,8, 130-134
  •   Request permissions

    Exploring inhibitor structural features required to engage the 216-loop of human parainfluenza virus type-3 hemagglutinin-neuraminidase

    I. M. El-Deeb, P. Guillon, L. Dirr and M. von Itzstein, Med. Chem. Commun., 2017, 8, 130
    DOI: 10.1039/C6MD00519E

Search articles by author

Spotlight

Advertisements